Date updated:04-22-2007
this is my picks on biotechology and drug stock

-
DNA
N/a - $80.43
- 0.00
- $80.43
the drug maker is in progress of doing a buyback of what was 6 billion now is 8 billion on high believes in the company . also, avastin was to be treated for patients with colorectal cancer and other types of cancer. then it is going into a next trail bases with the safety testing of the drug avastin.

-
GNTA
Gnta - $0.00
- N/A
- $N/A
on wednesday the drug maker released that the company will start on its late trail of its anticancer treatment drug genasense injection for patients with advance melanoma or skin cancer.
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. Charlie Munger
- 5. Calamos Advisors
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » Albo's First Portfolio
- » Fundsonly Portfolio 1
- » rk00005
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Nov. 11, 2009 Recently we put our short-squeeze focus on smaller stocks; this week we’re going large-cap. With higher trading volumes, mo...
By Jonas Elmerraji Posted on Nov. 10, 2009 After six straight days of gains, the markets are taking a breather today, which gives us the chance to focus our attention b...
By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...
By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...
A. The only one I own : SLX,
too hard pick a winner out all of them
Analyst Upgrades for Nov. 2, 2009. Read more here. more
Here is the stock list of some of the largest % losers from Nov. 2, 2009. more
Analyst Downgrades for Nov. 2, 2009. Read more here. more











Comments not available